M. E. Marzo

Validation of clinical control in COPD as a new tool for optimizing treatment

Juan José Soler‐Cataluña, M. E. Marzo, Pablo Catalán et al. · International Journal of COPD · 2018 · 61 citations · Full text

Medicine, Chronic Disease Control, Clinical Decision Support +16

Immunological profile of patients with primary progressive multiple sclerosis

Ignacio Durán, Eva Martínez‐Cáceres, Jordi Río et al. · Brain · 1999 · 60 citations

Life Sciences, Immunology, Neurology +16

Low‐dose steroids reduce flu‐like symptoms at the initiation of IFNP‐1b in relapsing‐remitting MS

Jordi Río, Carlos Nos, M. E. Marzo et al. · Neurology · 1998 · 46 citations

Medicine, Neurobiology, Neuroscience +17

Neurological impairment in α-mannosidosis: a longitudinal clinical and MRI study of a brother and sister

E Mayayo, M. E. Marzo, S Guelbenzu et al. · Child s Nervous System · 1999 · 25 citations

Medicine, Neurology, Neuroscience +7

Spanish real-world experience with fingolimod in relapsing-remitting multiple sclerosis patients: MS NEXT study

Francisco Javier Barrero, J Mallada-Frechín, María Luisa Martínez‐Ginés et al. · PLoS ONE · 2020 · 13 citations · Full text

Pharmacy, Neurology, Pharmacotherapy +9